Religious debate [Regulatives / Guidelines]

posted by nobody – 2016-02-14 16:23 (3776 d 22:39 ago) – Posting: # 15990
Views: 38,697

Hi Danmark :-D

❝ PK in drug development is all about impressing the assessor with complex models having a million effect estimates of dubious value. It is not about making sense. Just sayin'...


I heard in the past that each and every piece of modeling (wherever submitted in the EU when any kind of non-national marketing authorization is applied for) is going for review to Sweden.

I would not build any relevant argumentation on models clearly identifiable as nonsense in this situation, huh? ;-)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
153 visitors (0 registered, 153 guests [including 23 identified bots]).
Forum time: 16:03 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5